Showing results (41-50 of 135) with videos related to
Sort By:
Pageof 14
Cancers|September 27, 2025
Cancer Growth and Invasion Are Increased in the Tight Skin (TSK) MouseMaria Sol Recouvreux, Barbie Taylor-Harding, Amy C Rowat, et al.Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cellsMichael S Goldberg, Deyin Xing, Yin Ren, et al.Cancer Letters|April 2, 2015
Reduced expression and growth inhibitory activity of the aging suppressor klotho in epithelial ovarian cancerIrina Lojkin, Tami Rubinek, Sandra Orsulic, et al.Gynecologic Oncology|July 24, 2020
Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse modelEnes Taylan, Fouzia Zayou, Ramachandran Murali, et al.Cancer Immunology Research|June 10, 2015
Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer ModelLei Wang, Zohreh Amoozgar, Jing Huang, et al.International Journal of Cancer|August 30, 2008
Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse modelJiangyong Miao, David Mu, Burce Ergel, et al.Cancer Cell|June 28, 2002
Induction of ovarian cancer by defined multiple genetic changes in a mouse model systemSandra Orsulic, Yi Li, Robert A Soslow, et al.Gynecologic Oncology|September 9, 2015
Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activationZhenqiu Liu, Jessica A Beach, Hasmik Agadjanian, et al.Cancer Research|May 4, 2005
Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancerTakiko Daikoku, Dingzhi Wang, Susanne Tranguch, et al.Cells|December 11, 2022
Dynamic Changes in the Extracellular Matrix in Primary, Metastatic, and Recurrent Ovarian CancersArkadiusz Gertych, Ann E Walts, Keyi Cheng, et al.Pageof 14